Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  BeiGene, Ltd.    BGNE

BEIGENE, LTD.

(BGNE)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/11/2019 11/12/2019 11/13/2019 11/14/2019 11/15/2019 Date
191.72(c) 196.31(c) 197.3(c) 196.4(c) 198.25(c) Last
376 304 425 165 202 438 370 918 518 770 Volume
-3.87% +2.39% +0.50% -0.46% +0.94% Change
More quotes
Financials (USD)
Sales 2019 435 M
EBIT 2019 -707 M
Net income 2019 -724 M
Finance 2019 269 M
Yield 2019 -
Sales 2020 405 M
EBIT 2020 -867 M
Net income 2020 -934 M
Finance 2020 857 M
Yield 2020 -
P/E ratio 2019 -14,4x
P/E ratio 2020 -13,4x
EV / Sales2019 27,0x
EV / Sales2020 27,5x
Capitalization 12 019 M
More Financials
Company
More about the company
Surperformance© ratings of BeiGene, Ltd.
Trading Rating : Investor Rating :
More Ratings
Latest news on BEIGENE, LTD.
11/15BEIGENE, LTD. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
11/14BEIGENE : FDA Gives Accelerated Approval to BeiGene's Brukinsa
DJ
11/12BEIGENE : Management's Discussion and Analysis of Financial Condition and Result..
AQ
11/12BEIGENE, LTD. : Results of Operations and Financial Condition (form 8-K)
AQ
11/07BEIGENE : Monthly Return of Equity Issuer on Movements in Securities for the mon..
PU
11/05BEIGENE : Voluntary announcement - update regarding recent business developments
PU
11/05BEIGENE, LTD. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
11/05MIRATI THERAPEUTICS : Reports Third Quarter 2019 Financial Results
AQ
11/05BEIGENE : Seattle Genetics and BeiGene Announce Global License Agreement for Adv..
BU
11/01BEIGENE ALERT : Bragar Eagel & Squire, P.C. is Investigating BeiGene, Ltd. on Be..
BU
11/01Amgen To Invest In Chinese Biotech -- WSJ
DJ
10/31Amgen to Buy Stake in Chinese Cancer-Drugmaker BeiGene -- Update
DJ
10/31BEIGENE : Issue of subscription shares under specific mandate and continuing con..
PU
10/31BEIGENE : Change of date of audit committee meeting
PU
10/31AMGEN : BeiGene ADSs Up 23% on Amgen Deal
DJ
More news
News in other languages on BEIGENE, LTD.

- No features available -

More news
Sector news : Bio Therapeutic Drugs
11/14Walt Disney soars while Cisco disappoints
11/14THERMO FISHER SCIENTIFIC : Qiagen Shares Surge on Report Thermo Fisher Mulling D..
DJ
11/07GILEAD SCIENCES : U.S. Sues HIV Drugmaker Gilead Alleging It Infringed on PrEP P..
DJ
11/07GILEAD SCIENCES : U.S. Sues HIV Drugmaker Gilead Alleging It Infringed on PrEP P..
DJ
11/06Biogen Adding Ophthalmology Biosimilars in Deal With Samsung Bioepis
DJ
More sector news : Bio Therapeutic Drugs
Chart BEIGENE, LTD.
Duration : Period :
BeiGene, Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BEIGENE, LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 13
Average target price 214,44  $
Last Close Price 198,25  $
Spread / Highest target 30,1%
Spread / Average Target 8,16%
Spread / Lowest Target -24,3%
EPS Revisions
Sector and Competitors
1st jan.Capitalization (M$)
BEIGENE, LTD.41.34%12 019
GILEAD SCIENCES4.03%82 323
VERTEX PHARMACEUTICALS26.61%53 950
REGENERON PHARMACEUTICALS-7.67%37 702
WUXI APPTEC CO., LTD.81.65%22 459
GENMAB39.63%14 493